Revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Penumbra Inc (PEN)
Price$322.21Cached quote
Net income
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847.1M | $747.6M | $560.4M | $547.4M | $444.9M | $333.8M | $263.3M | $186.1M | $125.5M | $88.8M |
| Gross profit | $942.4M | $755.0M | $682.6M | $535.2M | $475.4M | $338.2M | $372.0M | $292.5M | $217.1M | $170.8M | $124.1M | $82.8M | $57.9M |
| Gross margin | 67.14% | 63.20% | 64.49% | 63.18% | 63.59% | 60.34% | 67.95% | 65.75% | 65.06% | 64.88% | 66.66% | 66.00% | 65.14% |
| Research & development | $89.8M | $94.8M | $84.4M | $79.4M | $104.6M | $90.0M | $51.7M | $36.2M | $31.7M | $23.9M | $18.0M | $15.6M | $14.1M |
| Operating expenses | $753.2M | $745.7M | $609.1M | $529.1M | $482.9M | $377.1M | $324.5M | $293.4M | $216.0M | $172.2M | $119.9M | $79.8M | $59.0M |
| Operating income | $189.2M | $9.3M | $73.6M | $6.1M | −$7.5M | −$38.9M | $47.5M | −$852,000 | $1.2M | −$1.4M | $4.2M | $3.0M | −$1.1M |
| Operating margin | 13.48% | 0.78% | 6.95% | 0.72% | −1.00% | −6.95% | 8.68% | −0.19% | 0.35% | −0.51% | 2.25% | 2.40% | −1.27% |
| EBITDA | $206.7M | $33.0M | $100.8M | $30.4M | $8.9M | −$26.1M | $55.6M | $5.3M | $4.9M | $947,000 | $5.9M | $3.8M | −$449,000 |
| EBITDA margin | 14.73% | 2.76% | 9.52% | 3.59% | 1.19% | −4.65% | 10.16% | 1.19% | 1.48% | 0.36% | 3.19% | 3.00% | −0.51% |
| Net income | $177.7M | $14.0M | $91.0M | −$2.0M | $5.3M | −$15.7M | $48.5M | $6.6M | $4.7M | $14.8M | $2.4M | $2.2M | $4.1M |
| Net profit margin | 12.66% | 1.17% | 8.59% | −0.24% | 0.71% | −2.80% | 8.85% | 1.48% | 1.40% | 5.63% | 1.27% | 1.79% | 4.61% |
| Basic EPSper basic share | $4.57 | $0.36 | $2.37 | -$0.05 | $0.14 | -$0.44 | $1.39 | $0.19 | $0.14 | $0.49 | $0.09 | -$0.18 | $0.21 |
| Diluted EPSper diluted share | $4.52 | $0.36 | $2.32 | -$0.05 | $0.14 | -$0.44 | $1.34 | $0.18 | $0.13 | $0.44 | $0.08 | -$0.18 | $0.14 |
Owners
Reported shareholders
≈10.91%of listed shares
BlackRock, Inc.4.3M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | ≈10.91%4.3M shares |
HBK INVESTMENTS L P | ≈4.67%1.84M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈4.34%1.71M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | ≈4.23%1.67M shares |
STATE STREET CORP | ≈3.16%1.24M shares |
ExodusPoint Capital Management, LP | ≈2.77%1.09M shares |
Balyasny Asset Management L.P. | ≈2.77%1.09M shares |
JPMORGAN CHASE & CO | ≈2.72%1.07M shares |
GOLDMAN SACHS GROUP INC | ≈2.15%847.1K shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ≈2.12%834.9K shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈2.02%796.47K shares |
NORGES BANK | ≈1.91%752.24K shares |
UBS Group AG | ≈1.79%703.82K shares |
MILLENNIUM MANAGEMENT LLC | ≈1.78%700.61K shares |
Elsesser Adam | ≈1.73%683.04K shares |
MORGAN STANLEY | ≈1.50%591.82K shares |
AQR Arbitrage LLC | ≈1.43%563.87K shares |
WHITEBOX ADVISORS LLC | ≈1.29%506.88K shares |
Capital World Investors | ≈1.22%479.7K shares |
CITADEL ADVISORS LLC | ≈1.14%448.76K shares |
Percentages use 39.39M shares of this listed class outstanding on Jul 14, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Oct 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 2, 2026Form 4 · 10b5-1 | Grewal HarpreetDirector | SellCommon Stock | 100 | $328.22 | $32.8K | 8.7K |
| Mar 2, 2026Form 4 · 10b5-1 | Yuen MaggieChief Financial Officer | SellCommon Stock | 2.4K | $342.30 | $832.5K | 18.4K |
| Jan 6, 2026Form 4 · 10b5-1 | Grewal HarpreetDirector | SellCommon Stock | 186 | $312.64 | $58.2K | 8.2K |
| Jan 2, 2026Form 4 · 10b5-1 | Wilder ThomasDirector | SellCommon Stock | 186 | $310.72 | $57.8K | 0 |
| Dec 11, 2025Form 4 · 10b5-1 | Bose AraniDirector | SellCommon Stock · indirect | 1.9K | $312.20 | $591.6K | 258.5K |
Community posts
Penumbra’s thrombectomy business leads 16% quarterly sales growth
Penumbra ($PEN) reported third-quarter 2026 revenue of $410.1 million, up 15.6%, as demand for its clot-removal systems expanded. Thrombectomy sales increased 18.1% to $279.2 million, including 26% growth in the US venous-thromboembolism bu ...
